Blog

 

Blog

Relocation of the European Medicines Agency – France shows EMA its smooth moves

29 June 2017

The bids to host the EMA are in. You can find the bid documents and videos here. In case you missed it, you can read our own pitches written by our colleagues across Europe here.

By Cécile Derycke and Charles-Henri Caron

With Brexit under way, the European Medicines Agency is looking for a new home. France revealed itself as a serious contender when it considered offering not just one hosting place for the Agency, but five! Up until recently, the cities of Strasbourg (in the east), Lille (in the north), Lyon (in central France), Montpellier (in the south) and the Ile-de-France region (suburban Paris) had expressed their willingness to welcome the EMA. The EMA would have had a tough time choosing between such beautiful and different regions. Not to worry! The French government has taken the matter into its own hands and it is Lille that officially represents France and offers EMA a smooth move. Close to London, the same type of weather (i.e. easy adjustment) and warm people to welcome the EMA staff - what could be better? But obviously, this is not France's only argument; it still has several more up its sleeve. 

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: France

Blog

Queen's speech paves the way for Brexit

21 June 2017

By Charles Brasted and Peter Watts

The Queen's Speech has set out the UK Government's intended legislative programme for the next two years – and its focus is Brexit. 

While there is little to no new detail, there are some further hints of how the Government intends to approach the task of implementing Brexit in the UK while negotiations with the EU continue.  

Read more

Jurisdictions: United Kingdom

Blog

Force Maijoor: supervisory convergence - a view of the impact from Italy

6 June 2017

By Jeffrey Greenbaum

On 11 April 2017, Steven Maijoor, the Chair of the European Securities and Markets Authority ("ESMA") addressed the potential regulatory issues which may affect EU Member States as a result of the Brexit effect on passporting rights ceasing to work across UK and EU borders. He noted that ESMA would work to eliminate "competition on regulatory and supervisory practices between member states, and a possible race to the bottom". On 31 May ESMA announced its general principles to support supervisory convergence in the context of the United Kingdom withdrawing from the European Union (the "General Principles"). Among other things, the principles call for rigorous and efficient authorisations and state there cannot be any automatic recognition of the authorisation granted by the UK regulator into the EU27.

Read more

Industries: Financial Institutions
Jurisdictions: Italy
Services: Financial Services

Blog

Relocation of the EU Medicines Agency – Spain

2 June 2017

By Álvaro Abad

"Spain is waiting for the EMA.  Barcelona is ready".  With this conviction, and with the conviction that everything is ready, the Spanish Minister for Health addressed the European Commissioner for Health & Food Safety, Mr Vytenis Andriukaitis, to express the desire of the Spanish Government – and, in particular, the Catalonia Government and the city of Barcelona – to become the next headquarters of the EMA.

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: Spain

Blog

Relocation of the EU Medicines Agency – Germany

8 May 2017

By Dr. Tanja Eisenblaetter

"EMA" and "gErMAny" – far more in common than mere letters

The European Medicines Agency (the "EMA"/"Agency") has reached celebrity-style status in the aftermath of the Brexit vote, and is being wooed by most European countries.  Whilst there are plausible arguments for a relocation of the EMA to any one of those wonderful European countries with delicious food, I wish – all prejudices against German food aside and I won’t mention Bratwurst – to point out some germane facts. gErMAny's bond with the EMA is already close – and not merely because it is in our name.  Each of the letters we share actually stands for a compelling reason for the Agency to relocate to Germany:

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: Germany